What Was Behind Anacor's 28% Climb?

This episode of The Motley Fool's Market Checkup dives into the hottest headlines, looks at the biggest market movers in the health-care sector, and discusses the implementation of the Affordable Care Act.

This segment from the show focuses on Anacor's  (NASDAQ: ANAC  )  28% surge after it announced that it will get $100 million from an arbitration ruling against drugmaker Valeant Pharmaceuticals (NYSE: VRX  ) . Analysts David Williamson and Max Macaluso discuss the impact of this ruling on both stocks in the following video.

Incredible growth stock to watch

This incredible tech stock is growing twice as fast as Google and Facebook, and more than three times as fast as Amazon.com and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2690290, ~/Articles/ArticleHandler.aspx, 7/23/2014 8:41:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement